More Post from the Author
- Genomma Lab Internacional Announces Results for the First Quarter 2025
- Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
- PHARMA AI COUNCIL (PAC) STARTET ZUR BESCHLEUNIGUNG DER INNOVATION UND DES VERANTWORTUNGSVOLLEN EINSATZES DER KOGNITIVEN TECHNIK IN DEN BIOWISSENSCHAFTEN
- Blue Earth Therapeutics initiates Phase 2 Clinical Trial evaluating the efficacy and safety of Lutetium (177Lu) rhPSMA-10.1 Injection in metastatic castrate resistant prostate cancer
- S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial
Sunset World Group Released the Results of its 2024 Sea Turtle Protection Program at Sunset Royal Beach Resort
Published on Fri 31 Jan 2025 8:37:53 UTC
CANCN, Mexico, Jan. 30, 2025 /PRNewswire/ -- The sea turtle nesting season in the Mexican Caribbean is every year between May and November and one of the beaches that receives the most turtles is the Sunset Royal hotel. That is why Sunset World Group has actively participated in the Sea Turtle Protection Program since 2009 as part of its firm commitment to the conservation of the biodiversity of our ecosystems.
More Post from the Author
- Genomma Lab Internacional Announces Results for the First Quarter 2025
- Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
- PHARMA AI COUNCIL (PAC) STARTET ZUR BESCHLEUNIGUNG DER INNOVATION UND DES VERANTWORTUNGSVOLLEN EINSATZES DER KOGNITIVEN TECHNIK IN DEN BIOWISSENSCHAFTEN
- Blue Earth Therapeutics initiates Phase 2 Clinical Trial evaluating the efficacy and safety of Lutetium (177Lu) rhPSMA-10.1 Injection in metastatic castrate resistant prostate cancer
- S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial